Calcipotriene
Showing 1 - 25 of 144
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022
Effectiveness, and Safety ofFixed-dose Combination of
Not yet recruiting
- Plaque Psoriasis
- CAL/BDP PAD Cream
- (no location specified)
Mar 31, 2023
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023
Breast Cancer Trial in Boston (Topical Calcipotriene Ointment, Topical Vaseline)
Recruiting
- Breast Cancer
- Topical Calcipotriene Ointment
- Topical Vaseline
-
Boston, MassachusettsMassachusetts General Hospital
Nov 2, 2021
Nail Psoriasis Treated With Enstilar® to Assess Severity Change
Completed
- Nail Psoriasis
- Calcipotriene and betamethasone dipropionate aerosol foam
-
Pontevedra, SpainComplejo Hospitalario Universitario de Pontevedra
Jul 30, 2021
Squamous Cell Carcinoma Trial in Roanoke (Combination topical 5-fluorouracil 5% / calcipotriene 0.005% cream, Nourivan Base
Recruiting
- Squamous Cell Carcinoma
- Combination topical 5-fluorouracil 5% / calcipotriene 0.005% cream
- Nourivan Base Cream
-
Roanoke, VirginiaCarilion Clinic Dermatology and Mohs Surgery
Apr 26, 2021
Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses Trial in Boston, Saint Louis (Calcipotriol Only Product in
Not yet recruiting
- Immunotherapy
- +4 more
- Calcipotriol Only Product in Cutaneous Dose Form
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Psoriasis Trial in United States (Ruxolitinib phosphate cream, Dovonex® calcipotriene 0.005%, Diprolene® AF betamethasone
Completed
- Psoriasis
- Ruxolitinib phosphate cream
- +3 more
-
Vallejo, California
- +5 more
Feb 7, 2022
Actinic Keratoses Trial in New Orleans (Calcipotriene 0.005% Foam, Efudex 5% Topical Cream)
Terminated
- Actinic Keratoses
- Calcipotriene 0.005% Foam
- Efudex 5% Topical Cream
-
New Orleans, LouisianaTulane University Medical Center
Dec 3, 2020
Plaque Psoriasis, Psoriasis Trial in New York (Enstilar® foam, Vehicle foam)
Completed
- Plaque Psoriasis
- Psoriasis
- Enstilar® foam
- Vehicle foam
-
New York, New YorkMount Sinai West
Dec 29, 2020
Psoriasis Vulgaris Trial in Berlin (0.03% E6201, 0.1% E6201, 0.2% E6201)
Completed
- Psoriasis Vulgaris
- 0.03% E6201
- +11 more
-
Berlin, GermanyBioskin GmbH
May 18, 2021
Psoriasis Trial in Louisville (Apremilast 30mg, calcipotriene and betamethasone dipropionate)
Unknown status
- Psoriasis
- Apremilast 30mg
- calcipotriene and betamethasone dipropionate
-
Louisville, KentuckySkin Sciences, PLLC
Oct 7, 2020
Psoriasis Vulgaris Trial in United States (Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%, Enstilar® foam
Completed
- Psoriasis Vulgaris
- Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%
- +2 more
-
Encinitas, California
- +29 more
Aug 17, 2020
Plaque Psoriasis Trial in Louisville (Enstilar)
Completed
- Plaque Psoriasis
-
Louisville, KentuckyDermResearch, PLLC
Aug 25, 2020
Psoriasis Trial in East Windsor (Enstilar)
Unknown status
- Psoriasis
-
East Windsor, New JerseyPsoriasis Treatment Center of Central New Jersey
Apr 29, 2020
Alopecia Areata Trial in Aswan (Calcipotriol)
Recruiting
- Alopecia Areata
-
Aswan, EgyptFaculty of Dentistary - Aswan University
Jul 21, 2023
Central Centrifugal Cicatricial Alopecia Trial in Winston-Salem (Calcipotriol, Subject's already prescribed drug)
Not yet recruiting
- Central Centrifugal Cicatricial Alopecia
- Calcipotriol
- Subject's already prescribed drug
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 31, 2023
Graft Vs Host Disease Trial in Cincinnati (Calcipotriene)
Completed
- Graft Vs Host Disease
- Calcipotriene
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 10, 2019
Psoriasis Vulgaris Trial in Bergmannstrasse 5 (AKVANO-Calcipotriol formulation 1, AKVANO-Calcipotriol formulation 2, AKVANO
Completed
- Psoriasis Vulgaris
- AKVANO-Calcipotriol formulation 1
- +5 more
-
Bergmannstrasse 5, Berlin, Germanybioskin GmbH
Aug 3, 2022
Psoriasis Vulgaris, Fractional CO2 Laser Trial in Assiut (Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone
Completed
- Psoriasis Vulgaris
- Fractional CO2 Laser
- Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
- Fractional carbon dioxide (CO2) laser
-
Assiut, EgyptAssiut University
Aug 23, 2023
Acne Vulgaris Trial in Los Angeles (Calcipotriene, Placebo)
Completed
- Acne Vulgaris
- Calcipotriene
- Placebo
-
Los Angeles, CaliforniaUCLA Dermatology
Apr 18, 2019
Mild to Moderate Psoriasis Trial in Ahmedabad (AKP02/AKVANO cutaneous spray (calcipotriol 50 µg/g + betamethasone 0.5 mg/g/
Recruiting
- Mild to Moderate Psoriasis
- AKP02/AKVANO cutaneous spray (calcipotriol 50 μg/g + betamethasone 0.5 mg/g/ AKVANO)
- +2 more
-
Ahmedabad, IndiaLotus Multispeciality Hospital
Aug 9, 2022
Psoriasis Vulgaris Trial in Nice (Betamethasone-Calcipotriene Topical)
Completed
- Psoriasis Vulgaris
- Betamethasone-Calcipotriene Topical
-
Nice, FranceCHU de Nice
Apr 17, 2019
Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer Trial in Boston, Saint Louis (Calcipotriol Only Product in
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +4 more
- Calcipotriol Only Product in Cutaneous Dose Form
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 5, 2022